Correction: Montvidas et al. Prevalence of Primary, Prominent, and Predominant Negative Symptoms of Schizophrenia in Routine Inpatient Psychiatric Care. Medicina 2026, 62, 30
Jonas Montvidas, Edas Kačerginskis, Paulina Petraitytė, Eimantas Zauka, Virginija Adomaitienė
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
| Type of Predominant Negative Symptoms | Predominant Negative Symptoms % ( |
|---|---|
| EPA-4 | 14.6 (47) |
| EPA-5 | 9.3 (30) |
| PANSS20-AG | 15.2 (49) |
| PANSS24-AG | 11.8 (38) |
| MARDER20-AG | 14.2 (46) |
| MARDER24-AG | 10.5 (34) |
| PANSS20-BrP | 5.9 (19) |
| PANSS245-BrP | 3.4 (11) |
| MARDER20-BrP | 5.6 (18) |
| MARDER24-BrP | 3.7 (12) |
| PANSS20-CrP | 11.1 (36) |
| PANSS24-CrP | 6.8 (22) |
| MARDER20-CrP | 10.2 (33) |
| MARDER24-CrP | 6.8 (22) |
| BNSS3 | 13 (42) |
| BNSS4 | 11.1 (36) |
| SNS | 10.5 (34) |
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSchizophrenia research and treatment · Mental Health and Psychiatry · Bipolar Disorder and Treatment
Error in Author’s Name
In the original publication [1], there was a mistake in the author’s name.
The updated name and email should be the following:
Edas Kačerginskis, [email protected] (E.K.)
Error in Table
In Table 7, to reflect the prevalence of predominant negative symptoms evaluated with SNS, we have added a line of data [SNS 10.5 (34)] and the abbreviation SNS. The corrected Table 7 is as follows:
Text Correction
Due to the author’s negligence, some texts need to be updated in the Abstract and Sections 3.5 and 4.
In the Abstract, the sentence “The average prevalence of predominant negative symptoms, as measured by PANSS and BNSS, was 9.6%, whereas SNS reported 76.2%” should be updated to the following version:
“The average prevalence of predominant negative symptoms, as measured by PANSS and BNSS, was 9.6%, whereas SNS reported 10.5%”.
In Section 3.5, the sentence “Only a small fraction of the sample had predominant negative symptoms when evaluated with BNSS or PANSS, but the proportion was higher with SNS (76.2%, n = 246)” should be updated to the following version:
“Only a small fraction of the sample had predominant negative symptoms when evaluated with either BNSS, PANSS, or SNS.”
In Section 4, the sentence “The fact that SNS did not identify a higher prevalence of prominent negative symptoms compared to PANSS or BNSS but did identify a much higher prevalence of predominant negative symptoms (76.2%) might indicate that SNS is more sensitive to detecting predominant negative symptoms” should be updated to the following version:
“It was as sensitive in discerning predominant negative symptoms as BNSS or PANSS. In our opinion, it is important to mention that SNS has a much faster completion time (3–5 min) which makes it a good bedside screening tool.”
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
The reference list from the paper itself. Each links out to its DOI / PubMed record.